UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors

Science (American Association for the Advancement of Science), 2018-01, Vol.359 (6371), p.91-97

2018

Volltextzugriff (PDF)

KRASG12C inhibition using MRTX1257: a novel radio-sensitizing partner

Journal of translational medicine, 2023-10, Vol.21 (1), p.1-773, Article 773

2023

Volltextzugriff (PDF)

The MET/AXL/FGFR Inhibitor S49076 Impairs Aurora B Activity and Improves the Antitumor Efficacy of Radiotherapy

Molecular cancer therapeutics, 2017-10, Vol.16 (10), p.2107-2119

2017

Volltextzugriff (PDF)

An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancer

Molecular cancer, 2024-03, Vol.23 (1), p.61-61, Article 61

2024

Volltextzugriff (PDF)

2790: Lymphopenia after brain radiotherapy: what is the role of lymphocyte irradiation? An in-silico model

Radiotherapy and oncology, 2024-05, Vol.194, p.S3445-S3448

2024

Volltextzugriff (PDF)

Nonpersistent Nanoarchitectures Enhance Concurrent Chemoradiotherapy in an Immunocompetent Orthotopic Model of HPV+ Head/Neck Carcinoma (Adv. Mater. 28/2024)

Advanced materials (Weinheim), 2024-07, Vol.36 (28), p.n/a

2024

Volltextzugriff (PDF)

Nonpersistent Nanoarchitectures Enhance Concurrent Chemoradiotherapy in an Immunocompetent Orthotopic Model of HPV+ Head/Neck Carcinoma

Advanced materials (Weinheim), 2024-07, Vol.36 (28), p.e2400949-n/a

2024

Volltextzugriff (PDF)

CCR2-Dependent Recruitment of Tregs and Monocytes Following Radiotherapy Is Associated with TNFα-Mediated Resistance

Cancer immunology research, 2019-03, Vol.7 (3), p.376-387

2019

Volltextzugriff (PDF)

Combination of vascular disrupting agents and ionizing radiation

Critical reviews in oncology/hematology, 2013-05, Vol.86 (2), p.143-160

2013

Volltextzugriff (PDF)

Abstract 5668: CCL2/CCR2-driven monocyte recruitment to the tumor following radiotherapy influences the outcome of the treatment of head and neck cancer

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.5668-5668

2017

Volltextzugriff (PDF)

Differential therapeutic effects of PARP and ATR inhibition combined with radiotherapy in the treatment of subcutaneous versus orthotopic lung tumour models

British journal of cancer, 2020-09, Vol.123 (5), p.762-771

2020

Volltextzugriff (PDF)

Radio-induced lymphopenia in the era of anti-cancer immunotherapy

International review of cell and molecular biology, 2023, Vol.378, p.1

2023

Volltextzugriff (PDF)

LymphoDose: a lymphocyte dose estimation framework—application to brain radiotherapy

Physics in medicine & biology, 2024-05, Vol.69 (10), p.105009

2024

Volltextzugriff (PDF)

Low Doses of Radiation Increase the Immunosuppressive Profile of Lung Macrophages During Viral Infection and Pneumonia

International journal of radiation oncology, biology, physics, 2021-08, Vol.110 (5), p.1283-1294

2021

Volltextzugriff (PDF)

Preventing Radiation-Induced Injury by Topical Application of an Amifostine Metabolite-Loaded Thermogel

International journal of radiation oncology, biology, physics, 2019-08, Vol.104 (5), p.1141-1152

2019

Volltextzugriff (PDF)

TGFβ receptor inhibition unleashes interferon-β production by tumor-associated macrophages and enhances radiotherapy efficacy

Journal for immunotherapy of cancer, 2022-03, Vol.10 (3), p.e003519

2022

Volltextzugriff (PDF)

Abstract 2568: S49076, a MET, AXL, FGFR inhibitor, potentiates radiation therapy in subcutaneous and orthotopic models of lung cancer

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.2568-2568

2015

Volltextzugriff (PDF)

The vascular disrupting agent ombrabulin (AVE8062) enhances the efficacy of standard therapies in head and neck squamous cell carcinoma xenograft models

Investigational new drugs, 2013-04, Vol.31 (2), p.273-284

2013

Volltextzugriff (PDF)

Abstract 1307: Modulation of the immune environment in a preclinical orthotopic model of non-small cell lung cancer exposed to ablative doses of radiation

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.1307-1307

2022

Volltextzugriff (PDF)

Optimal dosing regimen of CD73 blockade improves tumor response to radiotherapy through iCOS downregulation

Journal for immunotherapy of cancer, 2023-06, Vol.11 (6), p.e006846

2023

Volltextzugriff (PDF)

Synergy of Radiotherapy and a Cancer Vaccine for the Treatment of HPV-Associated Head and Neck Cancer

Molecular cancer therapeutics, 2015-06, Vol.14 (6), p.1336-1345

2015

Volltextzugriff (PDF)

Abstract C219: Novel MET/FGFR/AXL kinase inhibitor S49076 exerts radiosensitizing activity in vitro and in vivo

Molecular cancer therapeutics, 2013-11, Vol.12 (11_Supplement), p.C219-C219

2013

Volltextzugriff (PDF)

Understanding the functions of tumor stroma in resistance to ionizing radiation: Emerging targets for pharmacological modulation

Drug resistance updates, 2013-02, Vol.16 (1), p.10-21

2013

Volltextzugriff (PDF)

IGF-1R targeting increases the antitumor effects of DNA-damaging agents in SCLC model: an opportunity to increase the efficacy of standard therapy

Molecular cancer therapeutics, 2013-07, Vol.12 (7), p.1213-1222

2013

Volltextzugriff (PDF)

DNA damage checkpoint inactivation: Adaptation and recovery

DNA repair, 2009-09, Vol.8 (9), p.1101-1109

2009

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(42)

Sprache

Englisch
(42)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors

KRASG12C inhibition using MRTX1257: a novel radio-sensitizing partner

The MET/AXL/FGFR Inhibitor S49076 Impairs Aurora B Activity and Improves the Antitumor Efficacy of Radiotherapy

An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancer

2790: Lymphopenia after brain radiotherapy: what is the role of lymphocyte irradiation? An in-silico model

Nonpersistent Nanoarchitectures Enhance Concurrent Chemoradiotherapy in an Immunocompetent Orthotopic Model of HPV+ Head/Neck Carcinoma (Adv. Mater. 28/2024)

Nonpersistent Nanoarchitectures Enhance Concurrent Chemoradiotherapy in an Immunocompetent Orthotopic Model of HPV+ Head/Neck Carcinoma

CCR2-Dependent Recruitment of Tregs and Monocytes Following Radiotherapy Is Associated with TNFα-Mediated Resistance

Combination of vascular disrupting agents and ionizing radiation

Abstract 5668: CCL2/CCR2-driven monocyte recruitment to the tumor following radiotherapy influences the outcome of the treatment of head and neck cancer

Differential therapeutic effects of PARP and ATR inhibition combined with radiotherapy in the treatment of subcutaneous versus orthotopic lung tumour models

Radio-induced lymphopenia in the era of anti-cancer immunotherapy

LymphoDose: a lymphocyte dose estimation framework—application to brain radiotherapy

Low Doses of Radiation Increase the Immunosuppressive Profile of Lung Macrophages During Viral Infection and Pneumonia

Preventing Radiation-Induced Injury by Topical Application of an Amifostine Metabolite-Loaded Thermogel

TGFβ receptor inhibition unleashes interferon-β production by tumor-associated macrophages and enhances radiotherapy efficacy

Abstract 2568: S49076, a MET, AXL, FGFR inhibitor, potentiates radiation therapy in subcutaneous and orthotopic models of lung cancer

The vascular disrupting agent ombrabulin (AVE8062) enhances the efficacy of standard therapies in head and neck squamous cell carcinoma xenograft models

Abstract 1307: Modulation of the immune environment in a preclinical orthotopic model of non-small cell lung cancer exposed to ablative doses of radiation

Optimal dosing regimen of CD73 blockade improves tumor response to radiotherapy through iCOS downregulation

Synergy of Radiotherapy and a Cancer Vaccine for the Treatment of HPV-Associated Head and Neck Cancer

Abstract C219: Novel MET/FGFR/AXL kinase inhibitor S49076 exerts radiosensitizing activity in vitro and in vivo

Understanding the functions of tumor stroma in resistance to ionizing radiation: Emerging targets for pharmacological modulation

IGF-1R targeting increases the antitumor effects of DNA-damaging agents in SCLC model: an opportunity to increase the efficacy of standard therapy

DNA damage checkpoint inactivation: Adaptation and recovery

Suchergebnisse filtern